SCHEMBL7047723

SCHEMBL7047723

Cc1ccc([N]N)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11844645 0.77 NPC1 (0.48) —
SCHEMBL5301634 0.77 NPC1 (0.48) —
SCHEMBL8718058 0.77 NPC1 (0.48) —
SCHEMBL11693067 0.73 NPC1 (0.61) —
SCHEMBL17446281 0.73 NPC1 (0.61) —
SCHEMBL11693056 0.73 NPC1 (0.61) —
SCHEMBL50078 0.73 ACHE (0.57) —
SCHEMBL255052 0.73 NPC1 (0.61) —
SCHEMBL1405393 0.73 NPC1 (0.61) —
P-Xylene SCHEMBL28206161 0.71 ACHE (0.80) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6610710-B2 Inflammatory bowel diseases, diabetes, tumor proliferation and tumor metastasis. AJINOMOTO CO., INC. (JP) 2003-08-26 — — US disclosed
US-20030114490-A1 New phenylalanine derivatives AJINOMOTO CO. INC (JP) 2003-06-19 — — US disclosed
EP-1243577-A1 NOVEL PHENYLALANINE DERIVATIVES Ajinomoto Co., Inc. (JP) 2002-09-25 — — EP disclosed
Send feedback